163 followers
Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives https://t.co/vxm1xoZk1W
Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives https://t.co/vxm1xoZk1W
Role of Immunotherapy in Platinum-Resistant Ovarian Cancer. Unfortunately 80% patients suffer recurrence within ~ 2 years, and the overall response rate for platinum-resistant epithelial Ov Ca to cytotoxic chemotherapies & PARP-inhibitors is too modes
Just published in Oncotargets and Therapy : Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives https://t.co/uYXh0QGJxE @dovepress #immunotherapy #ovarian #womenshealth